Wu et al. reported that U2AF1 mutations were observed at a frequency of 7.5% in 478 patients with MDS, with a notably higher prevalence of 13.2% in patients under the age of 40 years [37]. This evidence concerns the gene U2AF1 and myelodysplastic syndrome.